"Hypercalciuria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Excretion of abnormally high level of CALCIUM in the URINE, greater than 4 mg/kg/day.
Descriptor ID |
D053565
|
MeSH Number(s) |
C23.888.942.337
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypercalciuria".
Below are MeSH descriptors whose meaning is more specific than "Hypercalciuria".
This graph shows the total number of publications written about "Hypercalciuria" by people in this website by year, and whether "Hypercalciuria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2014 | 0 | 2 | 2 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypercalciuria" by people in Profiles.
-
ADCY10 frameshift variant leading to severe recessive asthenozoospermia and segregating with absorptive hypercalciuria. Hum Reprod. 2019 06 04; 34(6):1155-1164.
-
Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin. Oncologist. 2019 06; 24(6):e312-e317.
-
An 8-year-old with genu valgum: Answers. Pediatr Nephrol. 2019 04; 34(4):621-624.
-
Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis. J Clin Endocrinol Metab. 2014 Nov; 99(11):E2451-6.
-
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1a,24(S)Dihydroxyvitamin D2) in patients with advanced cancer. J Oncol Pharm Pract. 2015 Dec; 21(6):416-24.
-
A 250??g/week dose of vitamin D was as effective as a 50??g/d dose in healthy adults, but a regimen of four weekly followed by monthly doses of 1250??g raised the risk of hypercalciuria. Br J Nutr. 2013 Nov; 110(10):1866-72.
-
Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery. 2012 Mar; 151(3):477-83.